/research/taxonomy/term/567/all en /research/channels/news/diamond-therapeutics-signs-agreement-mcgill-university-research-low-dose-lsd-328282 <p>TORONTO,聽Feb. 4, 2021聽/CNW/ - Diamond Therapeutics Inc. ("<b>Diamond</b>"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement with聽黑料不打烊 University聽for the exclusive use of Dr.聽Gabriella Gobbi's聽groundbreaking studies with lysergic acid diethylamide (LSD), its mechanism of action on the brain, and its potential for use at low doses in the treatment of mental health disorders.聽</p> Wed, 11 Oct 2023 15:23:14 +0000 megan.liley@mcgill.ca 1257 at /research